Trials / Completed
CompletedNCT04809090
CO-ADAPT: Adaptive Environments and Conversational Agent Based Approaches for Healthy Ageing and Work Ability
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Tommaso Ciulli · Industry
- Sex
- All
- Age
- 40 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to identify effective methodologies to help people improve their ability to adapt to psychological stress.
Detailed description
The subjects involved will follow a Stress Management Training (SMT) to learn some techniques to manage stress in the workplace and to increase the effectiveness of the intervention will use an APP and a Conversational Agent (CA) an Artificial Intelligence (AI). The purpose of the smartphone Application (APP) and CA will be to help people identify their thoughts, help them understand their emotions and the events that generated them. The data collected and analyzed will be integrated into artificial intelligence to improve understanding of what people are writing. Based on these analyses, it will be possible to identify the many different variables that interact in cases where a subject shows signs of stress related to adapting to change in the work environment and possible resilience factors that contribute to decreasing the state of stress. Tests will be administered at the beginning, at the end of the meetings, and 3 months after the end of the sessions. Subjects will be divided into various groups to understand whether APP and CA have a significant impact in increasing psychological well-being and stress coping strategies.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | SMT | Standard 8 SMT (Stress Management Training) psychological interviews. |
| DEVICE | App CA | An APP together a CA (Conversational Agent). |
Timeline
- Start date
- 2021-03-09
- Primary completion
- 2021-07-30
- Completion
- 2022-01-30
- First posted
- 2021-03-22
- Last updated
- 2022-07-21
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT04809090. Inclusion in this directory is not an endorsement.